WuXi AppTec HK Shares Set Record High, Market Cap Tops HK$590 Billion on Court Ruling
WuXi AppTec's Hong Kong shares hit a record high of HK$202.6, lifting market capitalization above HK$590 billion, after a U. S. federal court barred the Defense Department from enforcing its 1260H designation. The company's A-shares rose 3.75% to RMB160.62, while its half-year net profit grew 29.43% to RMB11.080 billion on revenue of RMB28.897 billion. The ruling shields the contract research firm from immediate adverse effects during the judicial challenge.
During morning trading on August 10, innovative drug concepts remained active. Baihua Yiyao hit its fifth consecutive limit-up, Harbin Pharmaceutical posted its second limit-up, Baipusaisi rose over 18%, and stocks such as Ha Sanlian, Hisun Pharmaceutical, WuXi AppTec, and Zelgen also advanced. The pharmaceutical and biotech sector overall rose 1.49%, with 400 stocks gaining, including five limit-up stocks such as Baipusaisi and Kaikai Industrial; 80 stocks fell, with the biggest declines including Biolight, Sihuan Biological, and Weikang Pharmaceutical, down 19.99%, 7.67%, and 4.36%, respectively.
WuXi AppTec's A-shares hit a record high that day. As of 9:32 a. m. , the stock rose 3.75% to RMB160.62, with volume of 14.4325 million shares and turnover of RMB2.315 billion, representing a turnover rate of 0.58%. Its latest A-share total market value reached RMB397.258 billion. Margin trading data showed that as of August 7, the stock's two-margin balance stood at RMB5.251 billion, with financing balance of RMB5.174 billion, down RMB136 million over the past 10 days, a decline of 2.57%.
The company's interim report showed revenue of RMB28.897 billion in the first half, up 38.93% year on year; net profit of RMB11.080 billion, up 29.43%; basic earnings per share of RMB3.80; and weighted average return on equity of 13.19%.
In the Hong Kong market, after the morning open on August 10, WuXi AppTec's HK-listed shares again hit a record intraday high of HK$202.6, with market capitalization exceeding HK$590 billion. As of 10:01 a. , the stock was at HK$201.4, up 4.7%, with turnover exceeding HK$1.53 billion.
On the news front, the U. S. District Court for the District of Columbia ruled on August 7, 2026 (U. time), prohibiting the U. Department of Defense from enforcing or implementing the 1260H designation or taking any other action based on it. The ruling shields WuXi AppTec from the immediate adverse effects of the designation during the judicial review process. The company had previously filed a lawsuit challenging its inclusion on the 1260H list.